Sylvester Comprehensive Cancer Center
@SylvesterCancer • 9,099 subscribers
South Florida’s only NCI-designated cancer center. Transforming discoveries from research labs to benefit our patients and the entire community.
Videos
ICYMI: Earlier this year, the former U.S. Surgeon General warned of strong links between alcohol use and cancer risk. Sylvester researchers analyzed national data and found that alcohol-related cancer deaths in the U.S. nearly doubled from 1990 to 2021—rising from under 12,000 to over 23,000 annually. The increase is largely driven by men aged 20-54, while rates in women declined slightly. Dr. Chinmay Jani (Chinmay Jani) presented the findings at the 2025 ASCO Annual Meeting, where the abstract earned the ASCO Merit Award. Senior author Dr. Gilberto Lopes (gilberto lopes) calls for greater awareness and more in-depth research into alcohol’s role in cancer development. Learn more: #ASCO25
Sylvester Comprehensive Cancer Center45,284 次观看 • 1 年前
Our Sylvester doctors and researchers attended the ASCO Annual Meeting to connect, collaborate and inspire. Watch this recap summarizing our participation at the leading global #oncology conference, helping to shape the future of cancer care. #ASCO25 #OnlySylvester 🔬 Stephen D. Nimer, MD C. Ola Landgren, M.D. gilberto lopes Chinmay Jani Peter Hosein, MD
Sylvester Comprehensive Cancer Center40,404 次观看 • 1 年前
Five years after being awarded the prestigious National Cancer Institute (National Cancer Institute) designation, we’ve earned it again. 🙌 As the only NCI-designated center in South Florida, we were recognized for our transformational new programs and initiatives, expanding our impact in our community since the first NCI designation. Our commitment to pursuing cancer cures continues: #OnlySylvester #WeAreNCIDesignated
Sylvester Comprehensive Cancer Center48,194 次观看 • 1 年前
ICYMI: In newly diagnosed multiple myeloma (NDMM), the addition of daratumumab (D) to the KRd regimen significantly improved minimal residual disease (MRD) negativity. In the ADVANCE clinical trial (NCT04268498), 306 patients received either DKRd or KRd for 8 cycles. Results show a 2.5-fold increase in MRD negativity with DKRd (59% vs 36%). Despite some adverse events, no new safety concerns emerged. These promising results suggest DKRd should become the new standard for NDMM patients receiving KRd-based therapy. C. Ola Landgren, M.D. presented these findings at the 2025 ASCO Annual Meeting. Learn more: #ASCO25 #MMsm
Sylvester Comprehensive Cancer Center24,600 次观看 • 1 年前
During a routine lab test Jennifer Stone found she had abnormal proteins in her blood— an early sign of smoldering #myeloma. Learn about Jennifer's experience as the first patient enrolled in Sylvester Myeloma Institute's clinical trial through #remission. 🙌 Under C. Ola Landgren, M.D.'s leadership, Sylvester continues to offer enrollment in this open clinical trial, giving other patients the opportunity to benefit from innovative, personalized care. Learn more: #CancerResearchMonth University of Miami UMiami Health System
Sylvester Comprehensive Cancer Center19,101 次观看 • 1 年前
Our director, Stephen D. Nimer, MD, will receive the 2024 @ash_hematology Mentor Award tomorrow! 🙌 This honor recognizes his incredible impact on shaping the careers of over 100 physicians and scientists. Hear from his mentees about the profound influence he’s had on their lives. #ASH24
Sylvester Comprehensive Cancer Center11,919 次观看 • 1 年前
没有更多内容可加载